234 related articles for article (PubMed ID: 32026467)
21. Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma.
Lee SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg; 2019 May; 269(5):966-971. PubMed ID: 29462007
[TBL] [Abstract][Full Text] [Related]
22. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
[TBL] [Abstract][Full Text] [Related]
23. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors for recurrence of papillary thyroid carcinoma: analysis of 4,085 patients.
Ywata de Carvalho A; Kohler HF; Gomes CC; Vartanian JG; Kowalski LP
Acta Otorhinolaryngol Ital; 2021 Jun; 41(3):236-242. PubMed ID: 34264917
[TBL] [Abstract][Full Text] [Related]
25. Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma.
Feng JW; Ye J; Wu WX; Pan H; Qin AC; Jiang Y; Wu BQ
Front Endocrinol (Lausanne); 2020; 11():553577. PubMed ID: 33133013
[TBL] [Abstract][Full Text] [Related]
26. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma.
Shin CH; Roh JL; Song DE; Cho KJ; Choi SH; Nam SY; Kim SY
Am J Surg; 2020 Oct; 220(4):925-931. PubMed ID: 32081409
[TBL] [Abstract][Full Text] [Related]
28. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
[TBL] [Abstract][Full Text] [Related]
29. Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Surgery; 2017 Feb; 161(2):485-492. PubMed ID: 27593085
[TBL] [Abstract][Full Text] [Related]
30. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.
DiMarco AN; Wong MS; Jayasekara J; Cole-Clark D; Aniss A; Glover AR; Delbridge LW; Sywak MS; Sidhu SB
BJS Open; 2019 Jun; 3(3):299-304. PubMed ID: 31183445
[TBL] [Abstract][Full Text] [Related]
31. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
[TBL] [Abstract][Full Text] [Related]
32. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
[TBL] [Abstract][Full Text] [Related]
33. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
34. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
35. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
Ebina A; Sugitani I; Fujimoto Y; Yamada K
Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
[TBL] [Abstract][Full Text] [Related]
36. Hemithyroidectomy and ipsilateral central neck dissection for T1 low-risk papillary thyroid cancer: single-institution retrospective observational study.
Giordano D; Botti C; Piana S; Castellucci A; Frasoldati A; Zini M; Fornaciari M; Crocetta FM; Ghidini A
Eur J Endocrinol; 2022 Mar; 186(5):535-542. PubMed ID: 35230264
[TBL] [Abstract][Full Text] [Related]
37. Survival Analysis of Papillary Thyroid Carcinoma in Relation to Stage and Recurrence Risk: A 20-Year Experience in Pakistan.
Hassan A; Razi M; Riaz S; Khalid M; Nawaz MK; Syed AA; Bashir H
Clin Nucl Med; 2016 Aug; 41(8):606-13. PubMed ID: 27124680
[TBL] [Abstract][Full Text] [Related]
38. Recurrence pattern after conservative surgery for papillary thyroid carcinoma.
Kobayashi K; Takenouchi S; Mitani H; Yoshida T
Auris Nasus Larynx; 2014 Dec; 41(6):548-51. PubMed ID: 24976169
[TBL] [Abstract][Full Text] [Related]
39. Total thyroidectomy may be more reasonable as initial surgery in unilateral multifocal papillary thyroid microcarcinoma: a single-center experience.
Xue S; Wang P; Liu J; Chen G
World J Surg Oncol; 2017 Mar; 15(1):62. PubMed ID: 28302162
[TBL] [Abstract][Full Text] [Related]
40. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
